RGS16 as a Therapeutic Target to Overcome TGFβ-Induced Resistance in Adoptive T Cell Therapies 2250696
T cells, particularly CD8+ T cells, play a central role in immune defense against intracellular pathogens and in tumor immunosurveillance. However, within tumors, these cells often become functionally exhausted, limiting the effectiveness of T cell—based immunotherapies. To maintain self-tolerance and immune home...